Recursion Pharmaceuticals Inc (RXRX)
5.76
+1.25
(+27.72%)
USD |
NASDAQ |
Apr 11, 16:00
5.67
-0.09
(-1.56%)
After-Hours: 20:00
Recursion Pharmaceuticals Shareholders Equity (Quarterly): 1.035B for Dec. 31, 2024
View 4,000+ Financial Data Types:
Add
Browse
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Absci Corp | 179.13M |
| Corcept Therapeutics Inc | 679.59M |
| Catalyst Pharmaceuticals Inc | 727.63M |
| Enanta Pharmaceuticals Inc | 111.82M |
| Apellis Pharmaceuticals Inc | 228.54M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.449B |
| Total Liabilities (Quarterly) | 413.82M |
| Debt to Equity Ratio | 0.0265 |
| Current Ratio | 3.81 |
| Net Debt Paydown Yield | -0.19% |